Forbes

Forbes
Share

Forbes

 •  January 2

Antibiotic resistance continues to be a huge problem prompting many of my consults on hospitalized patients. Because of resistance—and sometimes from incorrectly claimed drug allergies by patients—we are forced to use more toxic antibiotics than would otherwise be needed. This is also more costly, usually requiring placement of a long-term IV...

Forbes

 •  December 20, 2017

In today’s social and political climate, public opinion and public action can galvanize and turn on an issue in an instant. We’re seeing it right now as the personal misconduct of public figures eviscerates careers and upends personal lives. We saw something similar on the political front happen not too long ago in healthcare when the Affordable...

Forbes

 •  September 12, 2017

Making something good come from a tragedy has been Ciarán and Orlaith Staunton’s mission since their 12-year old son Rory’s death from sepsis. Since then, they have been driven to educate about sepsis, and have been remarkably successful in their goals. Rory cut his arm during gym class. His teacher did not clean the wound, but put a Band-aid on...

Forbes

 •  August 6, 2017

Jade Erick, 30, died in March 2017 after California naturopathic doctor, Kim Kelly, gave her an intravenous (IV) preparation of curcumin, a chemical constituent in the Indian spice turmeric that is over-hyped in alternative medicine. An FDA report released yesterday found that Imprimis Pharmaceuticals (NASDAQ:IMMY), a compounding pharmacy based in...

Forbes

 •  March 27, 2017

A San Diego woman, Jade Erick, 30, recently died of cardiopulmonary arrest after receiving an intravenous injection of turmeric, a common spice in Indian food. Until the medical examiner’s investigation of Erick’s death is complete, the identity of the person who injected the herbal solution into her body will not be known. But local naturopathic...

Forbes

 •  August 5, 2015

The CDC optimistically just said that better communication between hospitals, nursing homes, and health departments could markedly reduce antibiotic resistant “superbug” infections. While a laudable idea, I’m afraid the plan is the stuff of dreams…or, in this case, computer models. Given my view from the trenches—working part-time in several ...

Forbes

 •  July 20, 2015

The hours and early days after a preterm birth or any other birth requiring neonatal intensive care can be a whirlwind. There are tubes and wires, beeps and alarms, wiggly lines and computer printouts, tests and medications… This isn’t the case for all preemies or all infants admitted to the neonatal intensive care unit (NICU), but it’s the ...

Forbes

 •  June 11, 2015

I didn’t see the tiny danger lurking in my own yard. Yet for Lyme disease awareness month, just ended, it seems I am learning experientially. I’ve had Lyme at least once before, and found three attached deer ticks on me just in 10 days. I may have had Lyme a second time, last year, but diagnostic tests are so poor that we don’t know. Here’s some ...

Forbes

 •  May 12, 2015

Drugs have always been manufactured in carefully controlled and expensive factories. Now a little biotech company has the radical notion that it can do away with that and turn individual human beings into their own walking, talking drug factories.
Elon Musk and the SpaceX Mars colonists, it’s time to step aside. There’s a new No. 1 most disruptive ...